Tuesday, January 26, 2021

The University of Toledo's Researcher, Dr. Amit Tiwari Awarded $1.4 Million to Advance Research in Promising New Chemotherapy for Triple Negative Breast Cancer

 

Melissa Paskvan 
and Dr. Tiwari
My TNBC researcher here in Toledo was just awarded another grant, this time from U.S. Department of Defense for $1.4 million to further his research in overcoming drug resistance in treatment therapy in Triple Negative Breast Cancer.  I am so proud to be a part of University of Toledo's Dr. Amit Tiwari's research team as their Patient Advocate Mentor for continued research on Triple Negative Breast Cancer.  Congratulations to D. Tiwari and his amazing team! I am glad that we found each other as partners in this fight against TNBC!

(Click link to story) 

UToledo Awarded $1.4 Million to Advance New Chemotherapy for Difficult-to-Treat Breast Cancer


"We are glad that you are part of our team.  Thank you for your wonderful spirit and passion to keep us moving forward." - Dr. Amit K. Tiwari